Nursing and Health Professions
Human immunodeficiency virus
100%
Physiotherapy
93%
Intensive Care Unit
91%
Physiotherapist
55%
Critical Illness
51%
Electrocardiographic Lead
50%
Predictive Value
50%
Health Practitioner
50%
Motor Dysfunction
50%
Nicotine Replacement Therapy
50%
Syringomyelia
50%
Muscle Strength
50%
Cohort Analysis
50%
Weakness
50%
Medication Compliance
50%
Clinical Evaluation
50%
Hip Fracture
50%
Nicotine Withdrawal
50%
Orphan
50%
Cerebrovascular Accident
50%
Quality of Life
35%
Combination Therapy
33%
Adverse Event
33%
Clinical Practice
31%
Length of Stay
25%
CD4 Lymphocyte Count
25%
Adverse Outcome
25%
Balance Disorder
25%
Vestibular Disorder
25%
Patient Satisfaction
25%
Patient Referral
25%
Care Coordination
25%
Volunteer
20%
Thematic Analysis
18%
Intensive Care
18%
Physiotherapist
18%
Clinical Outcome
16%
Correlation Coefficient
16%
Hair Analysis
16%
Self-Efficacy
16%
Kappa Statistic
16%
Anthropometry
16%
Patient Care
16%
Outpatient
16%
Tracheostomy
16%
Teaching Hospital
14%
Compliance
14%
Female Physician
12%
Staff Training
12%
Dependent Variable
12%
Medicine and Dentistry
Hip Fracture
100%
Physiotherapy
75%
Randomized Controlled Trial
56%
Syringomyelia
50%
Orphan
50%
Nicotine Withdrawal
50%
Electronic Cigarette
50%
Apoplexy
50%
Nicotine Replacement Therapy
50%
Physiotherapist
50%
Fragility Fracture
50%
Toe
50%
Clinical Trial
50%
Standing
50%
Case-Control Study
50%
Ulcerative Colitis
50%
Endoscopy
50%
COVID-19
50%
Avoidance Response
37%
Quality of Life
29%
Care Coordination
25%
Rehabilitation (Therapeutic Procedure)
25%
Limb
16%
Rescue Therapy
15%
Severe Acute Respiratory Syndrome Coronavirus 2
15%
Orthopedics
12%
Self Concept
12%
Cost-Effectiveness Analysis
12%
Patient-Reported Outcome
12%
Patient Referral
12%
Hydrotherapy
11%
Biological Product
10%
Colectomy
10%
Growth Hormone Releasing Factor
8%
Heel
8%
Volunteer
8%
Friedman Test
8%
Vaping
6%
Addictive Behavior
6%
Symptom Management
5%
Spinal Cord Injury
5%
Pain Modulation
5%
Multiple Sclerosis
5%
National Health Service
5%
Aminosalicylic Acid Derivative
5%
Tofacitinib
5%
Cyclosporine
5%
Drug Megadose
5%
Outpatient
5%
Surgeon
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cerebrovascular Accident
100%
Case-Control Study
100%
Normal Human
58%
Inflammatory Bowel Disease
56%
Ulcerative Colitis
55%
Vasoactive Intestinal Polypeptide
50%
Base
50%
Tenofovir
50%
COVID-19 Vaccine
50%
Abacavir
50%
SARS Coronavirus
46%
Tofacitinib
28%
Infliximab
27%
Clinical Trial
25%
Mercaptopurine
22%
Immunosuppressive Agent
16%
Pandemic
12%
Biological Product
12%
Infection
11%
Receptor
11%
Tert Butyl Methyl Ether
10%
Therapeutic Drug Monitoring
10%
Ammonium Acetate
10%
Acetic Acid Ethyl Ester
10%
Methanol
10%
Acetonitrile
10%
Buffer
10%
Growth Hormone Releasing Factor
8%
Aminosalicylic Acid
6%
Ciclosporin
6%
Janus Kinase Inhibitor
5%
Combination Therapy
5%
Ustekinumab
5%
Tumor Necrosis Factor Inhibitor
5%
Tumor Necrosis Factor
5%
Vedolizumab
5%
Crohn's Disease
5%
